Moderna (MRNA:NASDAQ) 第三季度业绩超预期并上调指引，股价上涨
· seekingalpha.com
Moderna (MRNA) 股价上涨，因其公布优于预期的2026年第三季度业绩并上调全年增长展望。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...